Cataracts are also known to develop in patients with deficiencies of cholesterol synthesis enzymes, such as SC4MOL deficiency, CDPX2, lathosterolosis and Smith-Lemli-Opitz syndrome (SLOS) [16,18–20]. Here, MSMO1 is linked to Smith-Lemli-Opitz syndrome.